Effect of surface modification on hydration kinetics of carbamazepine anhydrate using isothermal microcalorimetry

AAPS PharmSciTech

Volumn 4, Issue 1, 2003, Pages

  Otsuka, Makoto ^a   Ishii, Mika ^a   Matsuda, Yoshihisa ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Anhydrate; Carbamazepine; Dissolution kinetics; Hydration kinetic analysis; Stability; Surface modification

Indexed keywords

BUTANOL; CARBAMAZEPINE; WATER;

ADSORPTION; ARTICLE; CHEMICAL MODIFICATION; CHEMICAL PROCEDURES; CHEMICAL REACTION KINETICS; CONSTANTS AND COEFFICIENTS; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRUG STABILITY; ENERGY TRANSFER; EQUIPMENT DESIGN; HEAT TRANSFER; HUMIDITY; HYDRATION; INFRARED SPECTROSCOPY; ISOTHERMAL TITRATION CALORIMETRY; JAPAN; MATHEMATICAL MODEL; MEDICAL LITERATURE; MICROCALORIMETRY; PLOTS AND CURVES; POWDER; PROCESS MONITORING; SURFACE PROPERTY; TEMPERATURE; X RAY POWDER DIFFRACTION; CALORIMETRY; CHEMISTRY; CRYSTALLIZATION; KINETICS;

1-BUTANOL; CALORIMETRY; CALORIMETRY, DIFFERENTIAL SCANNING; CARBAMAZEPINE; CRYSTALLIZATION; DRUG STABILITY; HUMIDITY; KINETICS; POWDERS; WATER;

EID: 0141800054     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt040105     Document Type: Article

References (27)

1. FDA papers. Guidelines: manufacturing and controls for INDs and NDAs. Pharm Tech Japan. 1985;1:835-850.
2. Haleblian JK. Characterization of habits and crystalline modification of solids and their pharmaceutical applications. J Pharm Sci. 1975;64:1269-1288.
3. Otsuka M, Matsuda Y. Polymorphism, pharmaceutical aspects. In: Swarbrick J, Boylan JC, eds. Encyclopedia of Pharmaceutical Technology. Vol 12. New York, NY: Marcel Dekker; 1995:305-326.
4. Stephenson GA, Stowell JG, Toma PH, Pfeiffer RR, Byrn SR. Solid-state investigations of erythromycin A dihydrate: structure, NMR spectroscopy, and hygroscopicity. J Pharm Sci. 1997;86:1239-1244.
5. Campen V, Amidon GL, Zografi G. Moisture sorption kinetics for water-soluble substances, III: theoretical and experimental studies in air. J Pharm Sci. 1983;72:1394-1408.
6. Campen V, Amidon GL, Zografi G. Moisture sorption kinetics for water-soluble substances, II: experimental verification of heat transport control. J Pharm Sci. 1983;72:1388-1393.
7. Kontny MJ, Zografi G. Moisture sorption kinetics for water-soluble substances, IV: studies with mixtures of solids. J Pharm Sci. 1983;74:124-127.
8. Vadas EB, Toma P, Zografi G. Solid-state phase transitions initiated by water vapor sorption of crystalline L-660, 711, a leukotriene D4 receptor antagonist. Pharm Res. 1991;8:148-155.
9. Nightingale SL. From the Food and Drug Administration. JAMA. 1990;263:1896.
10. Briggner L, Buckton G, Bystrom K, Darcy P. The use of isothermal microcalorimetry in the study of changes in crystallinity induced during the processing of powders. Int J Pharm. 1994;105:125-135.
11. Sebhatu T, Angberg M, Ahlneck C. Assessment of the degree of disorder in crystalline solids by isothermal microcalorimetry. Int J Pharm. 1994;104:135-144.
12. Angberg M, Nyström C, Castensson S. Evaluation of heat-conduction microcalorimetry in pharmaceutical stability studies, V: a new approach for continuous measurements in abundant water vapour. Int J Pharm. 1992;81:153-167.
13. Sheridan PL, Buckton G, Storey DE. Development of a flow microcalorimetry method for the assessment of surface properties of powders. Pharm Res. 1995;12:1025-1030.
14. Buckton G, Darcy P, Greenleaf D, Holbrook P. The use of isothermal microcalorimetry in the study of changes in crystallinity of spray-dried salbutamol sulphate. Int J Pharm. 1995;116:113-118.
15. Aso Y, Yoshioka S, Otsuka T, Kojima S. The physical stability of amorphous nifedipine determined by isothermal microcalorimetry. Chem Pharm Bull. 1995;43:300-303.
16. Rat M, Guillaume P, Wilker S, Pantel G. Practical application of microcalorimetry to the stability of propellants. Workshop Microcalorim Energ Mater. 1997;V1-V18.
17. Mimura H, Kitamura S, Koda S. Evaluation of drug stability by isothermal microcalorimetry [in Japanese]. Netsu Sokutei. 1998;25(4):92-96.
18. Giron D. Thermal analysis, microcalorimetry, and combined techniques for the study of pharmaceuticals. J Therm Anal Calorim. 1999;56(3):1285-1304.
19. Du W, Li X, Wang B, Zhang Y. A study on the interaction between cisplatin and urease. Thermochim Acta. 1999;333(2):109-114.
20. Beezer A, Gaisford S, Hills AK, Mitchell JC. Pharmaceutical microcalorimetry: applications to long-term stability studies. Int J Pharm. 1999;179(2):159-165.
21. Runge FE, Heger R. Use of microcalorimetry in monitoring stability. Example: vitamin A esters. J Agric Food Chem. 2000;48(1):47-55.
22. Tompa AS, Bryant WF Jr. Microcalorimetry and DSC study of the compatibility of energetic materials. Workshop Microcalorim Energ Mater. 1999;Q1-Q21.
23. Phipps MA, Mackin LA. Application of isothermal calorimetry in solid state drug development. Pharm Sci Technol Today. 2000;3(1):9-17.
24. Otsuka M, Ishii M, Matsuda Y. Effect of surface-modification on hydration kinetics of nitrofurantoin anhydrate. Colloids and Surfaces B: Biointerfaces. 2002;23:73-82.
25. Kaneniwa N, Yamaguchi T, Watari N, Otsuka M. Hygroscopicity of carbamazepine crystalline powders [in Japanese]. Yakugaku Zasshi. 1984;104:184-190.
26. Kaneniwa N, Ichikawa J, Yamaguchi T, Hayashi K, Watari N, Sumi M. Dissolution behaviour of carbamazepine polymorphs [in Japanese]. Yakugaku Zasshi. 1987;107(10):808-813.
27. Hixon A, Crowell J. Dependent of reaction velocity upon surface and agitation. Ind Eng Chem. 1931;23:923.